ILSUNG IS CO., LTD. (003120) Price & Analysis

― Followers

003120 Stock Chart & Stats

₩20750.00

₩650.00(3.23%)

Aug 20, 2026

―

Day’s Range― - ―

52-Week Range₩17,120.00 - ₩29,300.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)11.43K

Market Cap

₩247.13B

Enterprise Value-₩75.91K

Total Cash (Recent Filing)₩211.97B

Total Debt (Recent Filing)₩122.99M

Price to Earnings (P/E)35.2

Beta0.18

Next Earnings

Nov 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)571.11

Shares Outstanding13,300,000

10 Day Avg. Volume14,668

30 Day Avg. Volume11,426

Financial Highlights & Ratios

PEG Ratio-1.41

Price to Book (P/B)0.75

Price to Sales (P/S)4.51

P/FCF Ratio19.15

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

003120 FAQ

What was ILSUNG IS CO., LTD.’s price range in the past 12 months?

ILSUNG IS CO., LTD. lowest stock price was ₩17120.00 and its highest was ₩29300.00 in the past 12 months.

What is ILSUNG IS CO., LTD.’s market cap?

ILSUNG IS CO., LTD.’s market cap is ₩247.13B.

When is ILSUNG IS CO., LTD.’s upcoming earnings report date?

ILSUNG IS CO., LTD.’s upcoming earnings report date is Nov 18, 2026 which is in 89 days.

How were ILSUNG IS CO., LTD.’s earnings last quarter?

ILSUNG IS CO., LTD. released its earnings results on Aug 14, 2026. The company reported ₩30.291 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is ILSUNG IS CO., LTD. overvalued?

According to Wall Street analysts ILSUNG IS CO., LTD.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does ILSUNG IS CO., LTD. pay dividends?

ILSUNG IS CO., LTD. pays a N/A dividend of ₩1200 which represents an annual dividend yield of N/A. See more information on ILSUNG IS CO., LTD. dividends here

What is ILSUNG IS CO., LTD.’s EPS estimate?

ILSUNG IS CO., LTD.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does ILSUNG IS CO., LTD. have?

ILSUNG IS CO., LTD. has 13,300,000 shares outstanding.

What happened to ILSUNG IS CO., LTD.’s price movement after its last earnings report?

ILSUNG IS CO., LTD. reported an EPS of ₩30.291 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.244%.

Which hedge fund is a major shareholder of ILSUNG IS CO., LTD.?

Currently, no hedge funds are holding shares in KR:003120

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

ILSUNG IS CO., LTD.

Founded in 1954, Ilsung Pharmaceuticals Co., Ltd. operates as a key pharmaceutical firm in South Korea, headquartered in Seoul. The company specializes in the development and distribution of a comprehensive range of medicinal products. Its extensive portfolio includes antibacterial agents, pain management drugs, muscle relaxants, anticoagulants, various cardiovascular and circulatory system treatments, diagnostic contrast agents, diabetes therapies, gastrointestinal medicines, antiviral compounds, anti-emetic medications, respiratory care solutions, anesthetics, and antipyretics.